NYSE$HI
Hillenbrand Inc · Q1 2025 earnings
Q1 2025 earnings · · After market close · Investor relations
Briefing
Hillenbrand reported fiscal first quarter 2025 results, announced the sale of a majority stake in its Milacron injection molding and extrusion business, and updated its full-year guidance.
Hillenbrand's fiscal first quarter 2025 results were in line with expectations, with revenue decreasing 9% year-over-year to $707 million and adjusted EPS decreasing 19% to $0.56. The company announced the sale of a majority stake in its Milacron injection molding and extrusion business for $287 million, with net proceeds of approximately $250 million to be used for debt paydown. This transaction is part of Hillenbrand's portfolio transformation towards less cyclical, higher-growth opportunities.
- Revenue of $707 million decreased 9% compared to the prior year, aligning with Company expectations.
- Adjusted EPS of $0.56 decreased 19% compared to the prior year, also in line with Company expectations.
- Hillenbrand entered a definitive agreement to sell a majority stake in its Milacron injection molding and extrusion business for $287 million, with net proceeds of approximately $250 million for debt paydown.
- The transaction enhances the overall margin profile and focuses the portfolio on less cyclical, higher growth opportunities, reflecting continued portfolio transformation.
Headline financials
Revenue & EPS history
Hillenbrand · Revenue · Quarterly
$707M
Revenue by segment
Hillenbrand · $763M total across 2 segments · Q4 2023
- Advanced Process Solutions$516M+57.3%67.6%
- Molding Technology Solutions$247M-10.5%32.4%
Forward guidance
Hillenbrand is updating its annual guidance to reflect the majority sale of the Milacron business, which includes removing Milacron's consolidated results from the second half of the fiscal year, partially offset by reduced interest expense and expected equity income from the ownership stake. The company maintains its previous range for remaining businesses based on original foreign currency exchange rate assumptions.
Tailwinds
- Expected net proceeds of approximately $250 million from the Milacron sale will be used for debt paydown.
- The transaction enhances the overall margin profile of the company.
- The portfolio will be more focused on less cyclical, higher growth opportunities.
- The company maintains its previous outlook for remaining businesses, indicating stability.
- Customer quote pipelines remain healthy, reinforcing confidence in the long-term strategy.
Headwinds
- The Milacron transaction will remove its consolidated results from the second half of the fiscal year.
- The outlook does not assume a broad-based recession, which could impact results if it occurs.
- Potential impacts of tariff policy could extend beyond original assumptions for the year.
- Effects of foreign currency exchange rate fluctuations may extend beyond original assumptions for the year.
- The outlook does not assume a material impact from tariff policy or foreign currency fluctuations.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 8 quarterly earnings reports · overlaid with Q1 2025
-0.6%
Avg return
Earnings day
-0.9%
Avg return
5 days after
-3.7%
Avg return
30 days after
45%
29 / 64 earnings
Positive
+18.5%
Q3 2025
Best reaction
-16.3%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | — | — | — | |
| Q1 2026 | — | — | — | |
| Q4 2025 | +0.0% | +0.3% | +0.1% | |
| Q3 2025 | +18.5% | +26.8% | +29.6% | |
| Q2 2025 | -10.6% | -9.5% | -13.8% | |
| Q1 2025 | -7.3% | +1.1% | -18.7% | |
| Q4 2024 | +9.8% | +5.3% | +4.9% | |
| Q3 2024 | -6.9% | -14.0% | -25.7% | |
| Q2 2024 | -16.3% | -14.5% | -7.4% | |
| Q1 2024 | -6.6% | -2.6% | +1.1% | |
| Q4 2023 | -3.6% | — | — | |
| Q3 2023 | -6.3% | — | — | |
| Q2 2023 | -4.5% | — | — | |
| Q1 2023 | -6.1% | — | — | |
| Q4 2022 | +6.0% | — | — | |
| Q3 2022 | -0.1% | — | — | |
| Q2 2022 | -4.2% | — | — | |
| Q1 2022 | +0.8% | — | — | |
| Q4 2021 | +0.5% | — | — | |
| Q3 2021 | +0.7% | — | — | |
| Q2 2021 | -7.2% | — | — | |
| Q1 2021 | +0.1% | — | — | |
| Q4 2020 | +0.3% | — | — | |
| Q3 2020 | +6.5% | — | — | |
| Q2 2020 | +1.6% | — | — | |
| Q1 2020 | -2.1% | — | — | |
| Q4 2019 | -1.8% | — | — | |
| Q3 2019 | -7.3% | — | — | |
| Q2 2019 | -5.8% | — | — | |
| Q1 2019 | +6.5% | — | — | |
| Q4 2018 | -2.8% | — | — | |
| Q3 2018 | +4.0% | — | — | |
| Q2 2018 | -5.3% | — | — | |
| Q1 2018 | +2.6% | — | — | |
| Q4 2017 | +9.0% | — | — | |
| Q3 2017 | +0.4% | — | — | |
| Q2 2017 | +3.1% | — | — | |
| Q1 2017 | -3.1% | — | — | |
| Q4 2016 | +2.7% | — | — | |
| Q3 2016 | -0.7% | — | — | |
| Q2 2016 | -0.6% | — | — | |
| Q1 2016 | -6.4% | — | — | |
| Q4 2015 | -1.1% | — | — | |
| Q3 2015 | +5.7% | — | — | |
| Q2 2015 | +10.5% | — | — | |
| Q1 2015 | -6.4% | — | — | |
| Q4 2014 | +1.6% | — | — | |
| Q3 2014 | +1.4% | — | — | |
| Q2 2014 | -2.0% | — | — | |
| Q1 2014 | +7.0% | — | — | |
| Q4 2013 | +2.7% | — | — | |
| Q3 2013 | -1.1% | — | — | |
| Q2 2013 | -2.6% | — | — | |
| Q1 2013 | -1.0% | — | — | |
| Q4 2012 | +1.6% | — | — | |
| Q3 2012 | +2.1% | — | — | |
| Q2 2012 | +1.4% | — | — | |
| Q1 2012 | +0.0% | — | — | |
| Q4 2011 | +7.0% | — | — | |
| Q3 2011 | -8.4% | — | — | |
| Q2 2011 | -0.9% | — | — | |
| Q1 2011 | -0.7% | — | — | |
| Q4 2010 | -4.7% | — | — | |
| Q3 2010 | -4.8% | — | — | |
| Q3 2009 | -4.8% | — | — | |
| Q2 2010 | +1.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro